For a better experience, click the icon above to turn off Compatibility Mode, which is only for viewing older websites.

February

Examining Drexel’s Ties to the First African-American Women Physicians

February 26, 2016
Some of the country’s first African-American women physicians graduated from an institution that later grew into Drexel’s College of Medicine.
Read More
The Science of Eating Disorders

February 25, 2016
For National Eating Disorders Awareness Week, professors Adrienne Juarascio and Jessica Barson separate fact from fiction and weigh in on the psychological and physiological causes of eating disorders.
Read More
Drexel College of Medicine Transforms MD Program

February 24, 2016
The College is doing away with its two-track system and introducing a single curriculum designed to train more well-rounded, thoughtful physicians.
Read More
College of Medicine Students to Host 2016 Pediatric AIDS Benefit Concert

February 15, 2016
Proceeds from the student-run show on Feb. 20 will benefit the Dorothy Mann Center for Pediatric and Adolescent HIV.
Read More
Solved Protein Structure Holds Answers to Metabolic Disease That Afflicts Infants

February 15, 2016
Drexel researchers and an international group of scientists have made a critical step toward understanding a disorder that affects patients from birth into adulthood.
Read More
Learn about Established Status Epilepticus Treatment Trial (ESETT)

February 10, 2016

Status Epilepticus (SE) is defined as a seizure or recurrent seizures lasting longer than five minutes without stopping or waking up. A person whose seizure does not stop after receiving a full dose of medicine (benzodiazepines) to make it stop is considered to have Established Status Epilepticus (ESE).

Read More
Drexel Neurosciences Institute Part of Landmark Study Investigating Drug to Delay or Prevent Alzheimer's Disease

February 02, 2016

Researchers at Drexel Neurosciences Institute have begun a landmark study to determine if a new drug can postpone or even prevent Alzheimer's disease. The study examines healthy people whose brain scans show the build up of a protein associated with the disease — but who do not yet have any memory loss or other symptoms. The study will determine if an investigational treatment can clear the built-up plaque of the protein, called amyloid, before the disease progresses and brain cells are impaired.

Read More